Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to report pet exposure to human topical hormones
The VMD recommends that owners keep pets away from areas of skin where topical hormone products have been applied.

Animals can accidentally absorb hormones through everyday behaviours, like cuddling.

The Veterinary Medicines Directorate is urging vets to report incidents of pets being accidentally exposed to human topical hormone products.

The reminder is part of a series of VMD articles highlighting adverse events that often go underreported.

In this first article, the VMD highlights a review by the Swedish Medical Products Agency suggesting that pets may absorb oestrogen or testosterone by coming into contact with human skin where hormone gels and creams have been applied.

As forearms are a common application site for these treatments, everyday behaviours like cuddling or stroking pets can increase the chance of accidental absorption - a risk that many pet owners are not aware of.

Signs that a pet may have been accidentally exposed to topical hormone products vary by the animal’s sex and whether the animal absorbs oestrogen or testosterone. Female pets may show signs similar to being in heat, whether spayed or not, while males may develop swollen mammary glands and changes in testicular size.

To reduce these risks, the VMD recommends that owners keep pets away from areas of skin where topical hormone products have been applied and wash their hands with soap and water after application. The VMD also advises covering the application site with clean clothing once the product has dried.

Vets made aware of an adverse reaction after exposure to a human hormone product are urged to report it directly via the VMD’s adverse event reporting service.

It said: ‘The VMD will use reports to check if medicines continue to be safe and work as expected, to protect animal health, public health, and the environment’.

Image (C) Iryna Kalamurza/Shutterstock.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.